ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
TenX Keane Acquisition

TenX Keane Acquisition (TENK)

40,50
0,00
(0,00%)
Fermé 22 Décembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
40,50
Prix Achat
40,50
Prix Vente
15,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
40,50
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
6 653 077
Rendement du Dividende
-
Ratio Cours sur Bénéfices
2,70
Bénéfice par action (BPA)
0,36
Chiffre d'affairess
-
Bénéfice net
2,42M

À propos de TenX Keane Acquisition

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Siège social
Dover, Delaware, USA
Fondé
2024

TENK Dernières nouvelles

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an extraordinary general meeting held on August 2, 2024 Post-merger company expected to trade on...

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire CRANFORD, N.J., July 10, 2024 Multiple catalysts for potentially transformative assets in second half of...

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the “Company”), announced today that if the proposal to amend the Company’s Amended and...

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post transaction...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

New York, NY, July 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its...

TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022

New York, NY, Dec. 06, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the “Company”) (Nasdaq: TENKU), a newly incorporated blank check company, today announced that, commencing on December 8...

TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment Option

New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (NASDAQ:TENKU) (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted company...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TENK - Frequently Asked Questions (FAQ)

What is the current TenX Keane Acquisition share price?
The current share price of TenX Keane Acquisition is US$ 40,50
How many TenX Keane Acquisition shares are in issue?
TenX Keane Acquisition has 6 653 077 shares in issue
What is the market cap of TenX Keane Acquisition?
The market capitalisation of TenX Keane Acquisition is USD 269,45M
What is the 1 year trading range for TenX Keane Acquisition share price?
TenX Keane Acquisition has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of TenX Keane Acquisition?
The price to earnings ratio of TenX Keane Acquisition is 2,7
What is the reporting currency for TenX Keane Acquisition?
TenX Keane Acquisition reports financial results in USD
What is the latest annual profit for TenX Keane Acquisition?
The latest annual profit of TenX Keane Acquisition is USD 2,42M
What is the registered address of TenX Keane Acquisition?
The registered address for TenX Keane Acquisition is 3500 SOUTH DUPONT HIGHWAY, DOVER, DELAWARE, 19901
What is the TenX Keane Acquisition website address?
The website address for TenX Keane Acquisition is www.citiusonc.com
Which industry sector does TenX Keane Acquisition operate in?
TenX Keane Acquisition operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
120,01M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,64M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,95M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,61k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,4M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock